Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site
Clinical trial NCT00148135 · TERMINATED
Trial details
- NCT number
- NCT00148135
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-05-01
- Primary completion
- 2006-04-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.